Nutra Pharma Corp 's ability to collect accounts receivable sequentially worsen to 1.1, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Nutra Pharma 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 332 days, from 266 days, in the Mar 31 2026 quarter.

If we take a look into Consumer Non Cyclical sector 142 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2373 to 2573.

What is Receivable Turnover Ratio?
What is Nutra Pharma Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NPHC Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-18.41 %	30.6 %	203.77 %	461.23 %	494.82 %
Y / Y Revenue Change	-59.23 %	-63.17 %	-64.75 %	-6.34 %	63.47 %
Receivable Turnover Ratio (TTM)	1.1	1.37	1.79	2.65	3.48
NPHC's Total Ranking	# 2573	# 2373	# 0	# 2163	# 0
Accounts Receivable average collection period days	331	266	204	138	105
Seq. Receivable Change	-16.44 %	0.18 %	23.13 %	-20.84 %	33.76 %
Seq. Revenue Change	26.49 %	-5.61 %	-58.91 %	-16.9 %	14.27 %

Receivable Turnover Company Ranking
Within:	No.
Legal Cannabis Industry	# 15
Consumer Non Cyclical Sector	# 143
Overall Market	# 2573

Receivable Turnover Ratio Statistics
High	Average	Low
2.23	0.57	-0.06
(Sep 30 2014)		(Sep 30 2020)

NPHC Company Profile • Back to NPHC Efficiency Comparisons • Compare NPHC Receivables Turnover Ratio to its Competitors

Financial Statements
Nutra Pharma 's Accounts Receivable	$ 0 Millions	Visit NPHC's Balance sheet
Nutra Pharma 's Sales TTM	$ 0 Millions	Visit NPHC's Income Statement
Sources of NPHC's Revenues		Visit NPHC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Legal Cannabis Industry Accounts Receivable Turnover Trends and Statistics
Consumer Non Cyclical Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NPHC's Receivable Turnover Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NPHC's Growth Rates	NPHC's Roa	NPHC's Inventory Turnover Ratio	NPHC's Dividend Comparisons
NPHC's Profitability Ratios	NPHC's Roi	NPHC's Asset Turnover Ratio	NPHC's Dividend Growth
NPHC's Valuation Ratios	NPHC's Roe	NPHC's Financial Strength Ratios	NPHC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Consumer Non Cyclical Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Tradewinds Universal	2.71	$ 0.147 Millions	$ 0.054 Millions
American Vanguard Corporation	2.69	$ 510.994 Millions	$ 189.870 Millions
Nutra Pharma Corp	1.10	$ 0.161 Millions	$ 0.146 Millions
Bonk Inc	0.59	$ 3.610 Millions	$ 6.157 Millions

Date modified: 2026-08-20T08:10:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.